Crossmark

Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells

Crossref DOI link: https://doi.org/10.1136/jitc-2021-003826

Published Online: 2022-01-28

Published Print: 2022-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Tokatlian, Talar

Asuelime, Grace E

Mock, Jee-Young

DiAndreth, Breanna

Sharma, Shruti

Toledo Warshaviak, Dora

Daris, Mark E

Bolanos, Kristian

Luna, Breanna L

Naradikian, Martin S

Deshmukh, Kiran

Hamburger, Agnes E

Kamb, Alexander https://orcid.org/0000-0002-8675-6620
License Information

License valid from 2022-01-27